21:33 , May 11, 2018 |  BioCentury  |  Finance

Seroquel stepping stone

The $538 million acquisition by Luye Pharma Group Ltd. (HKSE:2186) of Seroquel quetiapine fumarate from AstraZeneca plc (LSE:AZN; NYSE:AZN) will lay the commercial groundwork in new emerging markets for the Chinese pharma’s internal CNS pipeline. On...
17:56 , May 11, 2018 |  BC Week In Review  |  Company News

Luye acquires AstraZeneca antipsychoitic for $538M

AstraZeneca plc (NYSE:AZN; LSE:AZN) granted Luye Pharma Group Ltd. (HKSE:2186) territorial rights to antipsychotic drug Seroquel quetiapine fumarate and its extended release formulation, Seroquel XL. Luye received rights in 51 countries and regions including China,...
16:13 , May 7, 2018 |  BC Extra  |  Company News

Luye paying AZ $538M for antipsychotic

AstraZeneca plc (NYSE:AZN; LSE:AZN) granted Luye Pharma Group Ltd. (HKSE:2186) territorial rights to antipsychotic drug Seroquel quetiapine fumarate and its extended release formulation, Seroquel XL. Luye received rights in 51 countries and regions including China,...
07:00 , Aug 1, 2016 |  BC Week In Review  |  Company News

Acino, Luye deal

Luye will acquire Acino’s transdermal drug delivery business for EUR245 million ($268.6 million). Acino said the deal is expected to close this half. The sale includes Acino’s transdermal manufacturing, distribution and R&D units. Luye said...
07:00 , Jul 26, 2016 |  BC Extra  |  Company News

Luye acquiring Acino's transdermal delivery business

Luye Pharma Group Ltd. (HKSE:2186) is to acquire the transdermal drug delivery systems (TDS) business from delivery play Acino Holding AG (Aesch, Switzerland) for EUR 245 million ($268.6 million). Luye said it sees "substantial growth...
07:00 , Sep 21, 2015 |  BC Week In Review  |  Company News

Acino sales and marketing update

Acino launched a generic version of Exelon Patch rivastigmine from Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland) in the U.S. Exelon Patch, an acetylcholinesterase (AChE) inhibitor, is approved in the U.S. to treat...
08:00 , Nov 17, 2014 |  BC Week In Review  |  Company News

Targovax management update

Targovax A/S, Lysaker, Norway   Business: Cancer   Hired: Gunnar Gardemyr as CEO, effective Jan. 12, 2015, currently a corporate advisor at Acino Holding AG, which Nordic Capital acquired   ...
07:00 , Oct 24, 2011 |  BC Week In Review  |  Company News

Acino Holding AG, Teva deal

Acino will acquire the Middle East and African business of Teva's Cephalon Inc. subsidiary for €60 million ($83.4 million) in cash and €20 million ($27.8 million) in shares. Acino said the business, which includes...
07:00 , Aug 23, 2010 |  BC Week In Review  |  Company News

SkyePharma management update

SkyePharma plc (LSE:SKP), London, U.K.   Business: Drug delivery   Hired: Axel Mueller as CEO, formerly CEO of Acino Holding AG, he will replace Ken Cunningham, who announced plans to step down in May   ...
00:10 , Aug 18, 2010 |  BC Extra  |  Company News

SkyePharma names Mueller CEO

Drug delivery company SkyePharma plc (LSE:SKP) hired Axel Mueller as CEO, effective Aug. 23. He was previously CEO of Acino Holding AG (SIX:ACIN). Mueller will replace Ken Cunningham, who announced plans to step down in...